These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 28277619)
1. Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells. Hütz K; Zeiler J; Sachs L; Ormanns S; Spindler V Mol Carcinog; 2017 Aug; 56(8):1884-1895. PubMed ID: 28277619 [TBL] [Abstract][Full Text] [Related]
2. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer. Han JY; Che N; Mo J; Zhang DF; Liang XH; Dong XY; Zhao XL; Sun BC BMC Cancer; 2024 Apr; 24(1):532. PubMed ID: 38671389 [TBL] [Abstract][Full Text] [Related]
3. Adhesion of pancreatic tumor cell clusters by desmosomal molecules enhances early liver metastases formation. Dietrich N; Castellanos-Martinez R; Kemmling J; Heuser A; Schnoor M; Schinner C; Spindler V Sci Rep; 2024 Aug; 14(1):18189. PubMed ID: 39107343 [TBL] [Abstract][Full Text] [Related]
4. Significance of desmoglein-2 on cell malignant behaviors via mediating MAPK signaling in cervical cancer. Zhou BX; Li Y Kaohsiung J Med Sci; 2020 May; 36(5):336-343. PubMed ID: 31930774 [TBL] [Abstract][Full Text] [Related]
5. Desmoglein 2 compensates for desmoglein 3 but does not control cell adhesion via regulation of p38 mitogen-activated protein kinase in keratinocytes. Hartlieb E; Rötzer V; Radeva M; Spindler V; Waschke J J Biol Chem; 2014 Jun; 289(24):17043-53. PubMed ID: 24782306 [TBL] [Abstract][Full Text] [Related]
6. Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer. Ramani VC; Hennings L; Haun RS BMC Cancer; 2008 Dec; 8():373. PubMed ID: 19091121 [TBL] [Abstract][Full Text] [Related]
7. TROP2 Down-regulated DSG2 to Promote Gastric Cancer Cell Invasion and Migration by EGFR/AKT and DSG2/PG/β-Catenin Pathways. Yang T; Jia L; Bian S; Chang X; Zhang Q; Tang Q; Zhu J; Yang Z; Feng Z Curr Cancer Drug Targets; 2022 Aug; 22(8):691-702. PubMed ID: 35392784 [TBL] [Abstract][Full Text] [Related]
8. EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2. Klessner JL; Desai BV; Amargo EV; Getsios S; Green KJ Mol Biol Cell; 2009 Jan; 20(1):328-37. PubMed ID: 18987342 [TBL] [Abstract][Full Text] [Related]
9. The most widespread desmosomal cadherin, desmoglein 2, is a novel target of caspase 3-mediated apoptotic machinery. Cirillo N; Lanza M; De Rosa A; Cammarota M; La Gatta A; Gombos F; Lanza A J Cell Biochem; 2008 Feb; 103(2):598-606. PubMed ID: 17559062 [TBL] [Abstract][Full Text] [Related]
11. Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injury. Gross A; Pack LAP; Schacht GM; Kant S; Ungewiss H; Meir M; Schlegel N; Preisinger C; Boor P; Guldiken N; Krusche CA; Sellge G; Trautwein C; Waschke J; Heuser A; Leube RE; Strnad P Mucosal Immunol; 2018 Nov; 11(6):1630-1639. PubMed ID: 30115995 [TBL] [Abstract][Full Text] [Related]
12. Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling. Kamekura R; Kolegraff KN; Nava P; Hilgarth RS; Feng M; Parkos CA; Nusrat A Oncogene; 2014 Sep; 33(36):4531-6. PubMed ID: 24166502 [TBL] [Abstract][Full Text] [Related]
13. Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion. Hartlieb E; Kempf B; Partilla M; Vigh B; Spindler V; Waschke J PLoS One; 2013; 8(1):e53739. PubMed ID: 23326495 [TBL] [Abstract][Full Text] [Related]
14. Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling. Kolegraff K; Nava P; Helms MN; Parkos CA; Nusrat A Mol Biol Cell; 2011 Apr; 22(8):1121-34. PubMed ID: 21325624 [TBL] [Abstract][Full Text] [Related]
15. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Ebert LM; Tan LY; Johan MZ; Min KK; Cockshell MP; Parham KA; Betterman KL; Szeto P; Boyle S; Silva L; Peng A; Zhang Y; Ruszkiewicz A; Zannettino AC; Gronthos S; Koblar S; Harvey NL; Lopez AF; Shackleton M; Bonder CS Angiogenesis; 2016 Oct; 19(4):463-86. PubMed ID: 27338829 [TBL] [Abstract][Full Text] [Related]
16. Enhanced desmosome assembly driven by acquired high-level desmoglein-2 promotes phenotypic plasticity and endocrine resistance in ER Liu B; Liu Y; Yang S; Ye J; Hu J; Chen S; Wu S; Liu Q; Tang F; Liu Y; He Y; Du Y; Zhang G; Guo Q; Yang C Cancer Lett; 2024 Sep; 600():217179. PubMed ID: 39154704 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of desmoglein 2 promotes EMT progression in gallbladder cancer. Wang L; Lv Y; Li J; Nan Y; Piao L; Liang Z Histol Histopathol; 2023 Apr; 38(4):467-474. PubMed ID: 36259602 [TBL] [Abstract][Full Text] [Related]
18. Serine/threonine-protein kinase D2-mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression. Liu YQ; Xu YW; Zheng ZT; Li D; Hong CQ; Dai HQ; Wang JH; Chu LY; Liao LD; Zou HY; Li EM; Xie JJ; Fang WK J Pathol; 2024 May; 263(1):99-112. PubMed ID: 38411280 [TBL] [Abstract][Full Text] [Related]
19. Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Nava P; Laukoetter MG; Hopkins AM; Laur O; Gerner-Smidt K; Green KJ; Parkos CA; Nusrat A Mol Biol Cell; 2007 Nov; 18(11):4565-78. PubMed ID: 17804817 [TBL] [Abstract][Full Text] [Related]
20. Plakoglobin but not desmoplakin regulates keratinocyte cohesion via modulation of p38MAPK signaling. Spindler V; Dehner C; Hübner S; Waschke J J Invest Dermatol; 2014 Jun; 134(6):1655-1664. PubMed ID: 24441103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]